TOKENPOST
1 min read
Add as a preferred source on Google

Taysha Gene Therapies Posts Third-Quarter 2026 Loss of $0.10 Per Share

The net loss per common share was the same on a basic and diluted basis.

By John Kim
Published
A frosted specimen vial stands beside offset ceramic blocks / TokenPost.ai
A frosted specimen vial stands beside offset ceramic blocks / TokenPost.ai

Taysha Gene Therapies posted a net loss per common share of $0.10 for the third quarter of 2026. The per-share loss was the same on a basic and diluted basis.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…